“Companies are realizing that investing stateside can provide more control and resilience to the drug supply chain,” says Dymowski. She cites political tensions, import and export disruptions, and ...

Tariffs and price inflation for specialty medications will increase costs, according to research from Vizient.

Trump's tariffs will not only impact sponsors, but higher costs will ripple down the clinical trial supply chain in the US.

West Pharmaceutical Services forecast full-year profit and revenue below Wall Street estimates on Thursday due to a strong dollar and as the medical equipment maker's clients reduce inventory levels, ...

President Trump’s tariffs in China are in place and hitting all products imported from the country — including a number of pharmaceutical drugs that Americans rely upon. Chinese imports ...

A statement from the Healthcare Distribution Alliance (HDA), which represents pharmaceutical distributors in the US, has said ...

Impacts of tariffs on the pharmaceutical industry, cutting-edge container monitoring and the sheer number of chicken wings ...

Experts at the 2025 Clinical Trial Supply Europe conference will explore supply chain challenges and the impact of AI on ...

Blockchain is poised to redefine pharmaceutical validation, offering unparalleled improvements in data integrity, compliance, ...